NantKwest and ImmunityBio Sign Collaboration Agreement for Joint Development, Manufacturing, Marketing, and Commercialization of COVID-19 Vaccine and…
stemadminMesenchymal Stem CellsNo comments

DetailsCategory: More NewsPublished on Monday, 24 August 2020 15:55Hits: 320 Both companies agree to share equally in costs relating to COVID-19 therapeutics and vaccine candidates globally; global net profits to be shared 60%/40% in favor of the company contributing the product EL SEGUNDO, CA & CULVER CITY, CA, USA I August 24, 2020 I NantKwest, Inc. (Nasdaq: NK), a clinical-stage, natural killer cell-based therapeutics company, and ImmunityBio, a privately held immunotherapy company, today announced the signing of a definitive agreement to jointly develop, manufacture, market, and commercialize therapeutics and vaccines for combating the COVID-19 pandemic.

Read more
Placental Stem Cell Collection and Storage Market Size, Key Trends, Challenges and Standardization, Research, Key Players, Economic Impact and…
stemadminMesenchymal Stem CellsNo comments

Placental Stem Cell Collection and Storage Market Los Angeles, United State:The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Placental Stem Cell Collection and Storage market. It sheds light on how the global Placental Stem Cell Collection and Storage Market is expected to grow during the course of the forecast period

Read more
Allogeneic Mesenchymal stem cells Market Is Expected To Experience An Impressive CAGR Growth Of XX% Through 2018 2028 – The Daily Chronicle
stemadminMesenchymal Stem CellsNo comments

In 2018, the market size of Allogeneic Mesenchymal stem cells Market is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2018; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. Persistence Market Research recently published a market study that sheds light on the growth prospects of the global Allogeneic Mesenchymal stem cells market during the forecast period (20XX-20XX). In addition, the report also includes a detailed analysis of the impact of the novel COVID-19 pandemic on the future prospects of the Allogeneic Mesenchymal stem cells market

Read more
3D Cell Cultures: Technologies and Global Markets to 2025 Featuring Agilent Technologies, BioVision, Cell Applications, Envisiontec, Mitra Biotech,…
stemadminMesenchymal Stem CellsNo comments

DUBLIN--(BUSINESS WIRE)--The "3D Cell Cultures: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The report includes: Whether the discussion is about stem cells, tissue engineering, or microphysiological systems, their vital role in drug discovery, toxicology, and other areas leading to new product development, 3D cell culture is becoming the environment that will increasingly define the basis for future advances

Read more
How Far Have We Come In Treating COVID-19? – The Dispatch
stemadminMesenchymal Stem CellsNo comments

Six months and counting into our coronavirus era, weve gotten much better at quantifying the fight against the disease. How well a country or state or county is faring is broken down into charts and scatterplots: Cases per capita and tests run per capita, hospital capacity and PPE availability, test positivity rate and test turnaround rate and case fatality rate. Given that blizzard of data, its strange that one question remains so difficult to examine: How much better are we actually getting at fighting the disease?

Read more
Stem Cell Therapy Market Size by Top Companies, Regions, Types and Application, End Users and Forecast to 2027 – Bulletin Line
stemadminMesenchymal Stem CellsNo comments

New Jersey, United States,- Verified Market Researchhas recently published an extensive report on the Stem Cell Therapy Market to its ever-expanding research database. The report provides an in-depth analysis of the market size, growth, and share of the Stem Cell Therapy Market and the leading companies associated with it. The report also discusses technologies, product developments, key trends, market drivers and restraints, challenges, and opportunities.

Read more
Cell Therapy for GVHD in Kids Faces Uncertain Fate in FDA Panel Review – MedPage Today
stemadminMesenchymal Stem CellsNo comments

WASHINGTON -- An FDA advisory panel on Thursday will decide whether to recommend approval of the investigational cellular therapy remestemcel-L for treating children with graft-versus-host disease (GVHD) following stem cell transplantation. No drugs are currently approved for the treatment of steroid-refractory acute GVHD in children under age 12, and the Oncologic Drugs Advisory Committee (ODAC) will be asked to vote on whether the available data support remestemcel-L's efficacy for pediatric patients with steroid-refractory acute GVHD. In a morning session, ODAC will review issues surrounding the manufacturing of remestemcel-L, which is described by sponsor Mesoblast as a product "comprising culture-expanded mesenchymal stem cells [MSCs] derived from the bone marrow of an unrelated donor." Patients with GVHD experience sustained systemic immune activation, and remestemcel-L's proposed mechanism of action is the reduction of these inflammatory processes mediated by the immunomodulatory bioactivity of MSCs

Read more

Theme: Illdy.